- Home
- OGI vs ARCT Comparison
OGI vs ARCT Comparison
Compare OGI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | ARCT |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.5M | 189.9M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OGI | ARCT |
|---|---|---|
| Price | $1.40 | $8.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $24.11 |
| AVG Volume (30 Days) | ★ 754.6K | 315.4K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | $20.10 | N/A |
| Revenue Next Year | $13.92 | $12.77 |
| P/E Ratio | $13.91 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $5.85 |
| 52 Week High | $2.24 | $24.14 |
Technical Indicators
Market Signals| Indicator | OGI | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 56.78 |
| Support Level | $1.30 | $6.90 |
| Resistance Level | $1.72 | $9.14 |
| Average True Range (ATR) | 0.08 | 0.41 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 22.22 | 44.39 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.